Robert Vriesendorp

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In 110 patients 127 radiocephalic arteriovenous fistulas were performed as vascular access for chemotherapy. If patients did not receive cytostatic agents prior to the operation or were treated for less than 4 weeks, the success rate of the operation was 75%. If chemotherapy was administered for longer than 4 weeks, it was possible to construct a(More)
OBJECTIVES The aim of the study was to test the antiviral efficacy of a triple nucleoside reverse transcriptase inhibitor (NRTI) regimen, with potential beneficial metabolic effects, as maintenance therapy after induction with dual NRTIs and a boosted protease inhibitor (PI). METHODS An open-label, noninferiority study was carried out. Antiretroviral(More)
Maintenance with a triple nucleoside reverse transcriptase Inhibitor (NRTI) regimen after successful induction with a dual NRTI/protease inhibitor (PI) combination may be advantageous, because of low pill burden, favorable lipids, and less drug interactions. This strategy to become free of PI-related problems without losing viral efficacy has not been(More)
  • 1